Tim Germann News Today

Icosagen Group, an established research-driven organization providing services for the discovery and production of mammalian cell-derived biopharmaceuticals, today announced that it has acquired the LSA® platform from Carterra®, a leading provider of high-throughput antibody screening and characterization ...

Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology (LJI), a globally recognized non-profit research organization dedicated to understanding the power of the immune system to promote human health, announced today that LJI has acquired a ...

Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology, a globally recognized non-profit research organization dedicated to understanding the power of the immune system to promote human health, announced today that LJI has acquired a Carterra LSA instrument to enhance its antibody screening and characterization work.

COVID-19 Consortium and resulting Science paper validated the Carterra platform as a game-changer in antibody discoverySALT LAKE CITY, Utah & LA JOLLA, Calif.--(BUSINESS WIRE)--Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology (LJI), a...

Wellcome Centre for Cell-Matrix Research is funding a nanobody screening project leveraging Carterra's platform The University of Manchester, United Kingdom, and Carterra, Inc., the world leader in

Carterra is a firm that provides technologies used in the discovery process for therapeutic treatments.

Carterra, Inc, the world leader in label-free high throughput antibody screening and characterisation, has announced that it has signed an exclusive Asia-Pacific and Oceania region distribution agreement with PerkinElmer, Inc, a global leader committed to innovating for a healthier world. Click to read more...